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Purpose: The purpose of this article is to examine the outcome of simultaneous coronary 
bypass-carotid endarterectomy (CABG-CEA) and to compare it with the outcome of 
endarterectomy alone (CEA alone) in patients at high cardiac risk. 
Methods: A retrospective r view of the records and follow-up data for 100 consecutive 
patients who had undergone CABG-CEA and were at high risk and 114 patients who had 
undergone CEA, had overt coronary artery disease (angina, previous infarct, or ischemic 
electrocardiographic abnormalities), but had not undergone CABG was carried out. 
Results: Our CABG-CEA group had a high incidence of symptomatic carotid disease 
(57%) and contralateral occlusion (28%) when compared with patients in other reports. 
Patients in the CABG-CEA group were older (67.9 + 8.3 years vs 63.6 + 15.7 years, 
p = 0.01) and more often smokers (81% vs 52.6%, p = 0.01) than patients in the CEA 
alone group. Perioperative mortality was 8% for the CEA-CABG group and 1.8% for the 
CEA alone group (p = 0.035). Perioperative stroke morbidity was 9% for the CEA-CABG 
group and 2.6% for the CEA alone group (p = 0.05). Life table survival at 1, 3, and 5 years 
was 90%, 82%, and 73% versus 96%, 84%, and 76% for the CABG-CEA and CEA alone 
groups, respectively (p = 0.30). 
Conclusions: Selection criteria for CABG-CEA greatly influence perioperative risk. Despite 
the greater age and more advanced coronary artery disease in the CABG-CEA group, 
long-term outcome differences are accounted for entirely by differences in perioperative 
morbidity and mortality. Prospective trials of strategies such as staged CEA and CABG to 
reduce perioperative risk are needed. (J Vase Surg 1996;24:58-64.) 
The association of coronary and carotid athero- 
sclerosis is established beyond oubt. 1 More than 50% 
of patients with carotid endarterectomy (CEA) have 
overt coronary disease (previous infarct, angina, or 
ischemic electrocardiographic abnormalities). 2 Rep- 
resentative series report that in patients undergoing 
coronary bypass, the incidence of duplex ultrasonog- 
raphy-detected ->50% carotid stenosis is 3.4% to 22%, 
whereas the incidence of _>80% stcnosis is 5.9% to 
12%. 3-~ Although simultaneous coronary bypass and 
CEA (CABG-CEA) has been advocated as an appro- 
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priate procedure for patients with critical coronary 
and carotid disease, supporting data are scant. 
Patient selection criteria for CABG-CEA differ 
widely interinstitutionally, and this in large part ex- 
plains the broad range of reported perioperative 
mortality and stroke morbidity results. 6,7 Because of 
disparate selection criteria and reported results, the 
proper role of CABG-CEA in the treatment of pa- 
tients with surgically treatable coronary and carotid 
disease remains difficult to define. 
The purpose of this article is the examination of 
our short- and long-term results in 100 consecutive 
patients undergoing CABG-CEA for consistent and 
well-defined indications. For perspective these results 
are compared with the results of  CEA carried out in 
114 patients With overt coronary disease. 
PAT IENTS AND METHODS 
Starting in October 1994 and worldng back in 
time, 100 consecutive patients who underwent 
CABG-CEA were identified and their charts re- 
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viewed. These 100 consecutive procedures were per- 
formed over a 10-year period (September 1984 
through October 1994) (average 10 cases per year, 
range 7 to 13 cases per year). Follow-up data were 
obtained by office visit or by telephone interview ith 
patients, 1their eferring physicians, or both. All pa- 
tients undergoing CEA and coronary bypass under a 
single episode of general anesthesia were included. 
Patients undergoing procedures in addition to CEA 
and coronary bypass (e. g., valve replacement/repair ) 
were included. 
The CEA alone group was identified in our carotid 
follow-up registry. Registry patients with overt coro- 
nary disease (previous myocardial infarction, angina 
pectoris, or ischemic electrocardiographic abnormali- 
ties) were selected. The 114 selected registry patients 
underwent carotid endarterectomy between Febru- 
ary 1980 and May 1986. Patients were excluded from 
this group if they had undergone CABG before CEA. 
Selection criteria for CABG-CEA during the pe- 
riod of this study were constant and clearly defined. 
Patients presenting for coronary bypass were deemed 
eligible for CABG-CEA if they had had recent ran- 
sient ischemic attacks or stroke referable to a 70% to 
99% carotid stenosis, or if they had no symptoms and 
had bilateral >70% stenoses or a unilateral occlusion 
and > 50% stenosis. Patients presenting for CEA were 
deemed candidates for CABG-CEA if their coexisting 
coronary symptoms were unstable, if their coronary 
anatomy eas judged to preclude safe endarterectomy, 
or both. Of  our patients in the CABG-CEA group, 57 
presented initially for CABG and were found to have 
incidental carotid disease, 13 presented for carotid 
endarterectomy and were found to have severe coro- 
nary disease requiring coronary bypass, and 30 had 
clear manifestations of surgical disease in both the 
carotid and coronary circulations. 
During the period in which these patients under- 
went surgery, we did not routinely screen the CABG 
group with carotid duplex scanning. A history of 
transient cerebral ischemia or stroke elicited during 
preoperative evaluation or detection of a neck bruit 
prompted further evaluation i most of our patients in 
the CABG-CEA group. Furthermore patients in the 
carotid endarterectomy group were not routinely 
screened with evocative stress testing before under- 
going surgery. Cardiac risk stratification was carried 
out on the basis of history, physical examination, and 
electrocardiography with only those patients deemed 
to be at highest risk subjected to further study) 
Standard statistical tests were used for data com- 
parisons, and statistical significance was inferred for 
p < 0.05. Perioperative events were defined as those 
occurring within 30 days of surgery or during the 
same hospitalization as the surgery. Life tables were 
constructed to conform to the standards set forth by 
the Committee on Reporting Standards of  the Society 
for Vascular Surgery/International Society for Car- 
diovascular SurgeryJ The log rank test was used for 
comparison of life table data. 
Our technique for combined CABG-CEA has 
been consistent. Two operating teams are used. The 
patient is anesthetized byour cardiac anesthesia team. 
While the cardiac team is harvesting vein, the vascular 
team performs the endarterectomy with selective 
shunting guided by electroencephalography criteria. 
Since 1991 vein patches have been used on virtually all 
cases.  
Demographic data for the CABG-CEA and the 
CEA alone groups are shown in Table I. Patients 
undergoing CABG-CEA were older (p = 0.014) and 
more frequently smokers (p= 0.01) than patients 
undergoing CEA alone. No statistically significant 
difference was seen between the groups in sex distri- 
bution or in the incidence of diabetes, hypertension, 
or previous myocardial infarction. No statistically 
significant difference was seen in duration of fol- 
low-up for the two groups. 
RESULTS 
Cardiac and carotid symptoms at presentation arc 
shown in Table II. Patients in the CABG-CEA group 
were much more likely to havc active cardiac symp- 
toms than those in the CEA alonc group. In addition, 
patients in thc CEA alone group were statistically 
significantly less likely to be operated for asymptom- 
atic carotid lesions. 
Left ventricular function data were available in 90 
of thc 100 patients in the CABG-CEA group. The 
mean ejection fraction was 50.3% + 12.2% with a 
range of 25% to 75%. Intraaortic balloon pumps were 
requircd in 11 patients; 6 were placcd during the 
operation, 3 before the operation, and 2 after the 
operation. Significant valvular disease was present in 
15 patients, and valve replacements or repairs were 
carried out in six (four mitral and two aortic). The 
aorta was judged to be heavily calcified in 14 paticnts. 
Routine intraoperative cpiaortic or transesophageal 
ultrasound imaging was not used. 
Patients in the CABG-CEA group had severe 
carotid disease. The mean ipsilateral stenosis was 
88.8% + 8.9% with a range of 50% to 99%. The mean 
contralateral stcnosis was 75.3% + 24.9% with a range 
of 10% to 100%. The contralateral carotid artery was 
occluded in 28 patients. Severe bilateral disease (>70% 
stenosis or occlusion) was present in 61 of 100 
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Table I. Demographic, risk factors, and duration of follow-up 
CABG-CEA CEA alone p 
Age (yr) 67.9 + 8.3 63.6 + 15.7 0.014 
Sex 
Male 68/100 73/114 
Female 32/100 41/114 0.62 
Smoking 81/100 60/114 0.01 
Hypertension 74/100 73/114 0.38 
Diabetes 30/100 24/114 0.19 
Previous MI 53/100 52/114 0.44 
Duration of follow-up (too) 42.6 + 34.1 39.8 _+ 23.1 0.48 
Table II. Symptoms at presentation 
CABG-CEA CEA alone p 
Cardiac 
Angina 87/100 46/114 <0.0001 
Prior MI 53/100 52/114 0.44 
Asymptomatic 5/100 30/114 0.0001 
Carotid 
TIA/TMB 49/100 65/114 0.42 
Prior stroke 19/100 20/114 0.80 
Global/Ver tebrobasilar 4/100 4/114 0.85 
Asymptomatic 43/100 31/114 0.05 
MI, Myocardial infarction; TIA, transient ischemic attack; TMB, transient monocular blindness. 
patients. Ipsilateral plaque ulceration was noted in 29 
patients. In the CEA alone group less detailed anglo- 
graphic data are available in 103 of 114 patients. Sixty 
patients had tight (>70%) ipsilateral stenoses, and 28 
had ulcerated plaques. Eleven patients were docu- 
mented to have contralateral carotid occlusion and 17 
to have critical contralateral stenosis. 
Perioperative mortality and morbidity data for the 
CABG-CEA group are shown in Table III. Periop- 
erative cardiac death occurred in 4 of 100 patients and 
was primarily related to cardiogenic shock. Three 
patients had clearly documented fatal perioperative 
myocardial infarctions, and one patient who under- 
went CABG-CEApIus mitral valve replacement had a 
low output state resulting in multisystem organ failure 
without evidence for myocardial infarction. Two fatal 
strokes occurred, one contralateral tothe endarterec- 
tomy and one in the brainstem ina patient with severe 
multivessel intracranial disease. 
Two deaths not related to cardiac or neurologic 
complications occurred. One was related to pneumo- 
nia with subsequent respiratory failure. This death 
occurred almost 5 months after surgery but is counted 
as perioperative, because it occurred uring the same 
hospitalization as the surgery. Another death was 
related to coagulopathy probably caused by severe but 
undetected liver disease. Most of the perioperative 
arrhythmias were minor and consisted of brief runs of 
atrial fibrillation. 
Of the nine perioperativc strokes in our CABG- 
CEA group, four were ipsilatcral to the endarterec- 
tomy. Three contralateral strokes, one of which 
proved fatal, occurred. One fatal brainstem stroke and 
one diffuse bilateral cerebral injury occurred. No 
strokes occurred in the six patients undergoing 
CABG-CEA and valve replacement or repair. In the 
CEA alone group three perioperative strokes oc- 
curred, all ipsilateral to the endarterectomy. 
During the period of time from which the CABG- 
CEA cases were analyzed, our cardiac surgery service 
was performing approximately 650 coronary bypasses 
per year without concomitant endarterectomy. Dur- 
ing this time mortality rates for CABG alone were 
approximately 2.3%, and annual CABG-associated 
stroke rates ranged from 2.0% to 3.6%. 
The mean postoperative l ngth of stay for the 
CABG-CEA group was 16.0 _+ 23.3 days with a range 
of 5 to 169 days in surviving patients. Sixty percent of 
patients had postoperative stays of 10 or fewer days, 
whereas 24% had stays exceeding 2 weeks. 
Perioperative mortality and stroke morbidity data 
for the CEA alone group are shown in Table IV. The 
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Table II I .  Perioperative mortality and morbidity for patients undergoing CABG-CEA 
Over~,ll mortality Cardiac Neurologic Other 
8/100 Cardiac death 4/100 Stroke death 2/100 Respiratory death 
Arrhythmia 33/100 Ipsilateral stroke 4/100 Coagulopathy death 
Pressors >24 hr 11/100 Contralateral stroke 3/100 
Perioperative MI 6/100 Bilateral strokes 1/100 
Sternal infection 1/100 Vertebrobasilar stroke 1/100 




MI, Myocardial infarction; TIA, transient ischemic attack. 
mortality rate of 1.8 % ( 2 of 114) and the stroke rate of 
2.6% (3 of 114) was statistically significantly better 
than those in the CABG-CEA group (8% mortality 
and 9% stroke) (p = 0.035 and p = 0.05). No statisti- 
cally significant difference was seen between the two 
groups in the incidence of perioperative stroke ipsi- 
lateral to the endarterectomy (4 of 100 vs 3 of 114) 
(p= 0.58). 
Life table survival data for the CABG-CEA and 
CEA alone groups are shown ~n Table V. Despite the 
marked ifference in early mortality between the two 
groups, no statistically significant difference was seen 
in long-term survival (p = 0.30). Of note is that only 
eight patients in the CEA alone group are known to 
have undergone coronary bypass during their post- 
endarterectomy follow-up. 
Life table stroke free survival data for the two 
groups are shown in Table VI. Despite the apparent 
initial disadvantage in the CABG-CEA group, no 
statistically significant difference was seen between 
the two groups in stroke-free survival (p = 0.19). 
The causes of late death are shown in Table VII. 
Note that the total number of late deaths hown in 
Table VII exceeds the number shown in Table V, 
because some of the late deaths occurred more than 6 
years after the operation. Of note is that the mean 
interval to late death was 52.1 + 31.4 months in the 
CABG-CEA group and 29.9 + 18.9 months in the 
CEA alone group (p = 0.01). 
DISCUSSION 
Myocardial infarction is the most frequent cause 
ofperioperative and late death after carotid endarter- 
ectomy. 2 Stroke complicates 1% to 4% of all coronary 
bypass operations, and the incidence ofpostcoronary 
bypass stroke is higher in patients with extracranial 
carotid isease.9a° There are manypotential causes for 
coronary bypass-related stroke (embolization from 
carotid, arch, endocardium, or pump-oxygenator, 
hypoperfhsion related to occlusive arterial lesions or 
hypotension, air embolizafion, intracerebral hemor- 
rhage). Our finding that five of nine perioperative 
Table IV. Mortality and morbidity in CEA 
alone group 
Condition N Percent 
Total mortality 2/114 1.8 
Total stroke 3/114 2.6 
Fatal stroke 1/114 0.9 
Nonfatal stroke 2/114 1.8 
Total MI 5/114 4.4 
Fatal MI 1/114 0.9 
Nonfatal MI 4/114 3.5 
MI, Myocardial infarction. 
strokes were not ipsilateral to the endarterectomy 
illustrates the multiple potential causes of stroke in 
this population. Because of the multiple potential 
cause of CABG-related stroke, it cannot be assumed 
that simultaneous endarterectomy will decrease the 
likelihood ofperioperative stroke. 
Because the Asymptomatic Carotid Atherosclero- 
sis Study (ACAS) has demonstrated that surgery is 
beneficial in long-term outcome for asymptomatic 
carotid lesions causing as little as 60% stenosis, and 
because carotid lesions of at least 60% will be encoun- 
tered in approximately 3% to 15% of patients under- 
going CABG, the proper role of combined CABG- 
CEA should be defined. 35,n 
Although the rationale for CABG-CEA is to 
minimize myocardial infarction and stroke risk in 
patients with severe athcrosclerosis in both the coro- 
nary and carotid arteries, our results suggest hat 
CABG-CEA carried out with our patient selection 
protocol and technique is associated with consider- 
able perioperative stroke morbidity (9%) and mortal- 
ity (8%) risk. This investigation was prompted by our 
dissatisfaction with these results. 
Morbidity and mortality rates for CABG-CEA 
appear highly dependent on patient selection criteria. 
Hcrtzer et al.6 documented a 4.2% mortality rate and 
a 2.8% stroke rate in 71 patients with unilateral 
asymptomatic arotid stenoses who underwent 
CABG-CEA. In 99 patients with severe bilateral 
disease or symptoms who underwent CABG-CEA, 
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Table V. Life table survival 
Time N No. dead 
CABG-CEA 
Cumulative 
Interval survival survival SEM 
30 Day 100 7 .93 .93 
3Mo 91 0 1.00 .93 .03 
6Mo 89 1 .99 .92 .03 
1Yr 84 2 .98 .90 .03 
2Yr 76 0 1.00 .90 .03 
3Yr 65 5 .92 .82 .04 
4Yr 48 3 .94 .77 .05 
5Yr 41 2 .95 .73 .05 
6Yr 31 3 .89 .65 .06 
CEAA~ne 
30 Day 114 2 .98 .98 
3Mo 112 1 .99 .97 .01 
6Mo 110 2 .98 .96 .01 
1Yr 106 0 1.00 .96 .02 
2Yr 101 4 .96 .92 .02 
3Yr 82 6 .92 .84 .03 
4Yr 53 1 .98 .82 .04 
5Yr 45 3 .92 .76 .05 
6Yr 31 1 .96 .72 .06 
Table VI. Life table strokefree survival 
CABG-CEA 
N No. stroke~dead Interval Cumulative SEM 
30 Day 100 13 .87 .87 
3Mo 86 0 1.00 .87 .03 
6Mo 84 0 1.00 .87 .03 
1Yr 80 1 .99 .86 .03 
2Yr 73 1 .99 .85 .03 
3Yr 62 4 .93 .79 .04 
4Yr 47 3 .93 .73 .05 
5Yr 40 3 .92 .67 .06 
6Yr 30 3 .89 .60 .06 
CEA Alone 
30 Day 114 4 .97 .97 
3Mo 110 1 .99 .96 .01 
6Mo 108 1 .99 .95 .02 
1Yr 105 0 1.00 .95 .02 
2Yr 100 5 .95 .90 .02 
3Yr 80 6 .91 .82 .03 
4yr 52 1 .98 .80 .05 
5Yr 44 4 .90 .72 .05 
6Yr 30 1 .95 .69 .07 
however, he noted a mortality of  6.1% and a stroke 
rate o f  7.1%, similar to our findings. In 34 patients 
with both bilateral stenoses and symptoms, the stroke 
rate was 21% with staged or combined procedures. 6 
Rizzo et al. 12 reported 127 CABG-CEA procedures 
with 5.5% mortality and 5.5% stroke morbidity. In 
patients with contralateral carotid occlusion the 
perioperative stroke rate was 15%, and in patients with 
previous troke it was 19%. Similarly, Cambria et al. ~3 
reported 4.2% stroke and 2.8% mortality rates in 71 
patients undergoing CABG-CEA.  In contrast o our 
patients, however, only 21% of  the patients in their 
series had severe bilateral stenoses or contralateral 
occlusion, and only 31% had symptoms. More re- 
cently, Chang et al. 14 reported 206 combined CABG- 
CEAs in 189 patients including 17 patients undergo- 
ing bilateral endarterectomies in conjunct ion with 
CABG, with mortality and stroke rates of  2% and 1%, 
respectively. Contralateral occlusion was present in 
only 13 (6.9%) patients and severe bilateral stenoses in 
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only 6 (3.2%) patients. One hundred fifty-five (82%) 
patients in this series had no symptoms. 
Other investigators have had less favorable results 
with simultaneous CABG and CEA. Curl et al.15 
recently reported astroke rate of 6.3% and a mortality 
rate of 11.7% in 34 patients at high risk undergoing 
CABG-CEA. Severe bilateral disease was present in 
17 (50%) patients. Coyle et al.7 reported on 65 
combined CABG-CEA procedures with periopera- 
tive stroke and mortality rates of 15.4% and 10.8%, 
respectivdy. 
Patient selection practices probably explain these 
widely disparate perioperative complication rates. 
Given the recently reported ACAS results, an ap- 
proach more liberal than ours to patients with surgical 
coronary disease and carotid lesions may be justified 
and reasonably safe, but alternative treatment s rate- 
gies in patients at lower risk could prove to be even 
safer. 
Long-term survival and strokefree survival in our 
CABG-CEA group are satisfactory and comparable to
those noted in our high-risk CEA alone group. No 
statistically significant difference was seen in survival 
or strokefree survival between the two groups, and 
the small difference noted is accounted for almost en- 
tirely by the differences inperioperative mortality and 
stroke morbidity. In fact, late mortality was delayed in 
the CABG-CEA group (52.1 + 31.4 months) when 
compared with the CEA alone group 29.9 + 18.9 
months) (p = 0.01). Minimizing perioperative mor- 
bidity and mortality istherefore key, if optimal results 
are to be achieved in these patients with severe multi- 
system atherosclerosis. 
Some authors have investigated a strategy of 
performing endarterectomy first, followed a few days 
later by coronary bypass (staged approach).6'l~'16 The 
rationale for this strategy isto decrease the stroke risk 
of CABG while eliminating the need for a lengthy and 
potentially more stressful simultaneous procedure. 
These potential beneficial effects may be offset by 
increased cardiac morbidity and mortality related to 
the endarterectomy. Obviously this approach is not 
applicable to patients whose cardiac status is un- 
stable. 
Another alternative strategy is coronary bypass 
followed a short time later by carotid endartereetomy 
(reversed staged approach). 6'17'1s The rationale for 
this approach is that cardiac morbidity and especially 
mortality pose a greater threat o the patient han do 
neurologic morbidity and mortality. CABG-related 
stroke risk may be highest with this strategy, but 
cardiac risk may be reduced. Few cardiac surgeons, 
however, would be willing to offer this approach to 
Table VII. Causes of late death 
CABG-CEA CEA alone 
Congestive failure 7/20 2/18 
MI/cardiac arrest 4/20 8/18 
Stroke 3/20 2/18 
Other 6/20 6/18 
MI, Myocardial infarction. 
patients with active carotid symptoms, critical bilat- 
eral stenoses, or both. 
Hertzer et al.6 evaluated staged versus simulta- 
neous versus reversed staged strategies. In this study 
129 patients with unilateral asymptomatic carotid 
lesions were eligible for randomization to simulta- 
neous versus reversed staged strategies. Mortality 
(4.2% vs 5.3%) and stroke morbidity (2.8% vs 14%) 
were lower in the simultaneous group, and the 
difference in stroke morbidity reached statistical sig- 
nificance (p = 0.042). Only 24 patients with very 
stable cardiac status were eligible for a staged strategy, 
which was associated with stroke and death rates of 
4.2%. Patients with more severe carotid and coronary 
disease (n = 122) were treated on a case-by-case basis, 
with 99 undergoing simultaneous CABG-CEA with 
6.1% mortality and 7.1% stroke morbidity rates and 23 
undergoing CABG followed by CEA with no mortal- 
ity but a stroke rate of 8.7% for the CABG and 7.4% for 
the subsequent delayed endarterectomy. No large- 
scale trials compare treatment outcomes in simulta- 
neous, staged, or reversed staged groups in a random- 
ized prospective manner. 
In summary, our patient selection criteria and 
management protocol are associated with significant 
perioperative mortality and stroke morbidity. Our 
results would almost certainly improve if we offered 
combined CABG-CEA to patients with unilateral 
asymptomatic carotid stenoses, and the ACAS data 
give justification for doing so. Despite our periopera- 
tive results, our long-term results uggest that these 
patients undergoing CABG-CEAwho are at high risk 
achieve survival and strokefree survival rates compa- 
rable to those of younger patients at lower risk with 
carotid and coronary disease treated with CEA alone. 
The benefits of the coronary bypass in these patients 
can be maximized only if the perioperative risk is 
minimized. Strategies (such as staging and reversed 
staging) designed to lessen perioperative risk in these 
patients must be investigated in a scientifically valid 
manner. Furthermore any study of strategies to re- 
duce perioperative morbidity and mortality must 
include detailed risk stratification, because as demon- 
strated when our experience is compared with those of 
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investigators offering CABG-CEA to lower risk co- 
horts,  results are highly dependent  on  identif iable 
preoperat ive factors. 
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